Podcast appearances and mentions of David Wang

Send us a textThe 3D InCites Podcast celebrates microelectronics industry innovation with a special episode featuring this year's award winners in heterogeneous integration and chiplet technology.• SallyAnn Henry, Jim Straus and David Wang, ACM Research, describe a horizontal rotation plating system for panel-level packaging with superior uniformity across square substrates• Eric Gongora, of MacDermid Alpha, explains how NovaFab fine-grained copper enables hybrid bonding with customizable annealing times and improved electron migration resistance• Chuck Woychik, NHanced Semiconductors, talks about how the company brings hybrid bonding capabilities onshore with expertise in wafer processing for both defense and commercial applications• Keith Felton, Siemens Digital Industries Software, introduces Innovator 3DIC for hierarchical device planning that automatically propagates design changes throughout chiplet interfaces• Kazuyuki Mitsukura explains how Resonac builds collaborative consortia in Japan and the US to solve complex advanced packaging challenges through shared resources• Rex Anderson from Micross shares his engineering journey and passion for mentoring the next generation of technologists• Ron Huemoeller and Eelco Bergman discuss how Saras Micro Devices addresses AI power challenges with embeddable S-Tile capacitors. They also talk about Saras corporate culture.EV Group EV Groups supplies high-volume equipment and process solutions for semiconductor manufacturing. KLA, SPTS Division KLA provides semiconductor equipment for metrology, inspection, wafer processing, and more. Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showBecome a sustaining member! Like what you hear? Follow us on LinkedIn and TwitterInterested in reaching a qualified audience of microelectronics industry decision-makers? Invest in host-read advertisements, and promote your company in upcoming episodes. Contact Françoise von Trapp to learn more. Interested in becoming a sponsor of the 3D InCites Podcast? Check out our 2024 Media Kit. Learn more about the 3D InCites Community and how you can become more involved.

Emotional health is deeply intertwined in an ongoing journey with spiritual health. This involves opening to our pain, grieving our trauma, and patiently cultivating a resilience that stabilizes and secures our relationships and our sense of self.With compassion, pastoral presence, and emotional attunement, psychologist Dr. David Wang is using psychological and theological tools to help us understand and adapt to emotional realities, explore the wounds of our past, and find healing and strength through acceptance and grief.In this conversation with David Wang, we discuss:The difference between human development and spiritual formation and how to understand maturityThe centrality of relationships in human life and growth, and how that's grounded in divine relationality and our communion with GodHow to become friends with ourselves, offering self-compassion and being moved by our own sufferingThe impact of childhood trauma on adult emotional, psychological, and spiritual healthAnd finally, how a practice of grief can help us understand and work through traumatic experiences and move toward healing.Show NotesChristian theology and formationA philosophical approach to theologically informed strategies for transformation and growthHow the relational aspects of God ground an approach to therapy and spiritual formationWhat are the markers of maturity?Relatedness and connection to others facilitates the process of human growth and developmentEmotional building blocks and relational capacities for maturityDave Wang on spiritual health and thrivingTheological and psychological frameworks of thrivingHolding the beautiful beside the brokenBecoming friends with ourselvesShow compassion, be moved by our own suffering, and accept limitations as we strive toward the hard work we're all called to.Two paradoxical needs to achieve spiritual maturity and healthWe are made for relationships, but we also need independenceBalanceSpiritual and emotional maturityFormation through practice, education, and healthy developmentCan virtue be taught?Can maturity be educated?Can we learn to thrive and be spiritually healthy?In the Realm of Hungry Ghosts, Dr. Gabor Maté writes that “The attempt to escape from pain is what creates more pain.”When our brains and our bodies go into survival modeAvoidance as a coping mechanism or strategyChildhood trauma in childhood“When the psychic pain is so unbearable, the felt threat so intimidating, we mentally and emotionally try to escape.”Childhood trauma can reemerge in adult behaviors, relationships, habits, language, even physical illness or conditions.Do I have trauma that I haven't dealt with?The symptoms or signs of traumaHow to approach the process of seeking help and healing.Concrete practices that can help and heal traumatic experienceLearning to grieveChristian spiritual practices of prayerThe emotional practice of grief and acceptanceDr. Pam King's Key TakeawaysHuman beings need both relationships and independence. And learning how to balance and integrate them is a marker of our maturity.Though we may try to escape from pain, to deal with trauma we need to practice acceptance and grief. It's a difficult and complex relational process that brings us closer to healing and wholeness.We can befriend ourselves in our pain through a practice of self-compassion.In this life, we have to hold beauty beside brokenness. Cultivating the capacity to do so is the hard work of growth into spiritual and emotional maturity, and the joyful journey of thriving.www.drdavidcwang.comhttps://www.seminaryformationproject.com/About David WangDr. David Wang is a licensed psychologist and Associate Professor of Psychology at Fuller Theological Seminary, where he's also the Cliff and Joyce Penner Chair for the Formation of Emotionally Healthy Leaders and scholar in residence at Fuller's Center for Spiritual Formation. He speaks and trains leaders globally on trauma informed care. And he conducts research and teaches courses in Trauma Therapy, Dialectical Behavior Therapy, Multicultural Psychology, and the Integration of Psychology and the Christian faith. He is also Pastor of Spiritual Formation at One Life City Church in Fullerton, California. About the Thrive CenterLearn more at thethrivecenter.org.Follow us on Instagram @thrivecenterFollow us on X @thrivecenterFollow us on LinkedIn @thethrivecenter About Dr. Pam KingDr. Pam King is Executive Director the Thrive Center and is Peter L. Benson Professor of Applied Developmental Science at Fuller School of Psychology & Marriage and Family Therapy. Follow her @drpamking. About With & ForHost: Pam KingSenior Director and Producer: Jill WestbrookOperations Manager: Lauren KimSocial Media Graphic Designer: Wren JuergensenConsulting Producer: Evan RosaSpecial thanks to the team at Fuller Studio and the Fuller School of Psychology & Marriage and Family Therapy.

Dr. Shaalan Beg and Dr. David Wang discuss key abstracts in GI cancers from the 2025 ASCO Gastrointestinal Cancers Symposium, including major advances in CRC, neoadjuvant approaches in esophageal cancer, and innovative studies on ctDNA. TRANSCRIPT Dr. Shaalan Beg: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg. I'm a medical oncologist and an adjunct associate professor at UT Southwestern Medical Center in Dallas. Today, we're bringing you some key highlights from the 2025 ASCO Gastrointestinal Cancers Symposium, and I'm delighted to be joined by the chair of GI25, Dr. David Wang. Dr. Wang is a GI medical oncologist at the University of Michigan. Our full disclosures are available in the transcript of this episode.  Dr. Wang, thanks for coming on the podcast today. Dr. David Wang: Well, thank you. It's a pleasure to be here. Dr. Shaalan Beg: GI25 featured major therapeutic advances across the spectrum of GI malignancies, and it was exciting to hear about innovations and novel approaches that are shaping the future of our field. Before we start talking about specific abstracts, could you share some of your key highlights from the meeting? Dr. David Wang: Sure. Our theme this year was “Breaking Boundaries to Enhance Patient Centered Care.” Past years' themes have focused more on precision oncology, but we wanted to broaden our focus on patients and to be more holistic, which kind of led us into some of the Intersection [sessions] that we had. Each day started with a different Intersection. The first one was “Emerging Therapies in GI Cancers”, where invited speakers talked about bispecific antibody drug conjugates, theranostics, CAR T and other cell-based therapies. The second day was on “Personalized Risk Assessment for GI Cancers,” and this included looking at polygenic risk scores for colorectal cancer, microRNAs and liquid biopsies such as exosomes and pancreatic cancer and non-endoscopic screening modalities in esophageal cancer. And on our final day, we wanted to talk about “Integrative Oncology and Integrative Medicine,” looking at evidence-based uses of acupuncture and supplements in patients who are receiving treatment for cancer, mindfulness-based practices and exercise. And of course, we had a fantastic keynote talk by Dr. Pamela Kunz from the Yale School of Medicine titled, “Disrupting Gastrointestinal Oncology: Shattering Barriers with Inclusive Science.” She highlighted the intersection of science, patient care, and health and gender equity. And I would encourage your podcast listeners to access the lecture in ASCO's Meeting Library if they haven't yet had a chance to hear Dr. Kunz's wonderful lecture.  We were really happy this year because the attendance hit a new record. We had over 5,000 people attend either in person or virtually from their home or office, and we had almost 1,000 abstracts submitted to the meeting, so these were either record or near record numbers. We offered a lot of different networking opportunities throughout the meeting, and attending found these to be incredibly rewarding and important and this will continue to be an area of emphasis in future meetings. Dr. Shaalan Beg: Let's take a deeper dive into the exciting studies presented at GI25. The late breaking abstract LBA143 was CheckMate-8HW. This was the first results of NIVO + IPI versus NIVO monotherapy for MSI-high metastatic colorectal cancer. What are your thoughts about this study? Dr. David Wang: Yeah, so we know that colorectal cancer patients with MSI-high tumors don't necessarily respond well to chemotherapy. And we were fortunate because last year CheckMate-8HW actually looked at two different arms – so this was NIVO + IPI compared to standard of care chemotherapy and showed its very significant improvement in median progression-free survival. And that was actually published in the New England Journal of Medicine back in November of 2024. This year's presentation actually focused now on NIVO + IPI versus NIVO monotherapy. And as you know IPI+NIVO can be quite toxic. So this was an important analysis to be done. So we know that NIVO is definitely more easily tolerated. So what was interesting was that the 2-year and 3-year progression-free survival not surprisingly favored IPI+NIVO and this was statistically significant. And the overall response rate was also better with IPI+NIVO versus NIVO alone. I know we're always concerned about toxicities and there were higher grade 3 and 4 toxicity incidences in the combination arm versus the monotherapy arm, but overall, only about 28 additional events in several hundred patients treated. So I think that's well-tolerated. Our discussant Dr. Wells Messersmith actually said that, with this new data, he would consider doing combination immunotherapy in any patient that presented in the front line with MSI-high or deficient mismatch repair colorectal cancer that was metastatic. Dr. Shaalan Beg: One of the focuses for directing first-line therapy for colorectal cancer has been right and left sided colon cancer because we know these are two different cancers with their own unique molecular subtypes. We heard on Abstract 17, the DEEPER trial, the final analysis of modified FOLFOXIRI plus cetuximab versus bevacizumab for RAS wild-type and left sided metastatic colorectal cancer. How do you summarize the findings of this study and what should our readers be aware of? Dr. David Wang: Interestingly, this was a phase 2 study and the emphasis of the abstract was actually a subgroup analysis of those patients with RAS wild-type and BRAF wild-type as well as left sided cancers. So, I think the entire study enrolled 359 patients, but the analysis that was discussed at the meeting really focused on 178 patients that fit that characteristic. Very similar to what we've seen in prior studies, left-sided tumors have better response to cetuximab versus bevacizumab. And if you flip it so that you now are looking at right sided tumors, targeting EGFR is actually detrimental. The depth of response was better with cetuximab in these left sided RAS and BRAF mutant tumors. And so the lead author actually suggested that this could be a new first-line standard of care. And the question is, is there a benefit of doing this triple agent regimen with modified FOLFIRINOX? We know there's a lot more toxicity with that. Not clear that there's a benefit for that over FOLFOX, maybe in younger patients that could tolerate it. When our discussant, again Dr. Wells Messersmith, spoke about this, he said that, in his practice he would, again, favor cetuximab over bevacizumab in combination with chemo, these left-sided RAS and BRAF wild-type tumors, but that he would actually prefer a doublet versus a triplet chemo regimen, and that is consistent with the current NCCN guidelines. Dr. Shaalan Beg: Another area where colorectal cancer has been a wonderful model to study new technology has been in the area of circulating tumor DNA (ctDNA). And the BESPOKE CRC trial is looking to see if ctDNA can inform adjuvant treatment decisions for stage II and III colorectal cancer. And in Abstract 15, we heard final results of the BESPOKE CRC sub-cohort. What were the findings there? Dr. David Wang: BESPOKE CRC is another one of these important ctDNA studies. It was an observational study, not a randomized trial, but it did provide a lot of different insights to us. We know that there were over 1,700 patients enrolled, and so it was reported that this is the largest ctDNA study in colorectal cancer performed in the United States. And they were able to analyze over 1,100 patients.  Some of the key findings were that postoperative adjuvant therapy management decisions actually changed in 1 out of 6 patients, so that's pretty significant. In terms of surveillance, we know that patients who have ctDNA positivity, this is prognostic of recurrence. In terms of patients who have positive ctDNA post-surgery, it looked like, at least in this observational study, the majority of patients who received any benefit were those who had positive ctDNA. So adjuvant therapy, even in stage II and stage III patients seemed to only benefit those patients who have positive ctDNA. I think that does raise the question, and this also was brought up in the discussion, which is “Can we de-escalate adjuvant therapy in terms of patients who are ctDNA-negative post-op?” And Dr. Richard Kim from Moffitt felt that we are not yet there. Obviously, we need randomized control trials where we are taking ctDNA results and then randomizing patients to receive adjuvant or non-adjuvant to really know the difference.  Other questions that come up with use of ctDNA include: What do you do with these patients who turn positive? This study for BESPOKE actually followed patients out to two years after surgery. So what you do with a positive ctDNA result wasn't really clear. It seems to suggest that once you turn positive, patients go on to more intensive surveillance. You know, again as an observation, patients who did turn positive were able to go to metastasis-directed therapy much more quickly. And again, this was supposedly to improve their curative intent therapy. And I think the other question that has been brought up all the time is, is this really cost effective? Patients want to know, and we want to give patients that information, but I think we're still stuck with what to do with a positive ctDNA level in a patient that's on surveillance because no randomized control studies have actually suggested that we need to start systemic therapy right away. Dr. Shaalan Beg: Yeah. And I guess in terms of practice informing or practice changing, these results may not give us a clear answer. But because a lot of patients are asking for these tests, it does give us some real world experiences on what to expect in terms of conversion of these positive into negative and the outcome so we can have a shared decision making with our patients in the clinic and then come up with a determination on whether ctDNA for molecular residual disease is something which would be worthwhile for the care of our patient. But more to come, I guess, in coming years to answer different problems around this challenge. Dr. David Wang: Yes, I agree. Dr. Shaalan Beg: The BREAKWATER trial looked at the use of encorafenib, cetuximab and chemotherapy for BRAF V600E-mutant metastatic colorectal cancer. We've covered this combination for a second- third-line treatment in metastatic colorectal cancer previously. Abstract 16 from GI25 was evaluating the use of this regimen in the first-line space. Everyone was looking forward to these results, and what did the investigators present? Dr. David Wang: I think this is, as you mentioned, a nice follow up to later lines of therapy where Dr. Kopetz from MD Anderson pioneered use of encorafenib, cetuximab and binimetinib in the BEACON trial. Everybody was kind of curious what would happen now if you use encorafenib plus cetuximab plus chemotherapy in the first-line setting. And so this is an interim analysis that was pre-planned in the phase 3 open label BREAKWATER trial. And even though there were three arms, and so the three arms were encorafenib plus cetuximab, encorafenib plus cetuximab plus FOLFOX, or standard of care chemo, only two arms were presented in the abstract. So basically looking at encorafenib plus cetuximab and FOLFOX-6 versus standard of care therapy, and the overall response rate was statistically significant with a 60.9% overall response rate encorafenib plus cetuximab plus chemo arm versus standard of care chemo was only 40%. The interim overall survival also was different. It was 92% versus 87% at 6 months and 79% versus 66% at 12 months, again favoring the chemotherapy plus encorafenib plus cetuximab. In terms of the statistics, the p was 0.0004. However, the pre-plan analysis required the p-value to be 1x10 to the -8. And so even though this looks really good, it hasn't quite met its pre-specified significance level. The good thing is that this is only interim analysis and the study is ongoing with future analysis planned.  So the real question is: Does it matter when we actually use this regimen? We know that the regimen's approved in the second third-line setting. What about in the first line? And there was some preclinical data that the discussant reviewed that shows that patients actually benefit if this is done in the first-line setting. For example, there was some preclinical data showing that even FOLFIRI, for example, can upregulate RAS, which would make tumors more resistant to this combination. This was thought to be practice-changing in a patient that has B600E showing up treatment naive that we should probably consider this regimen. And actually this did receive accelerated FDA approval about a month ago. Dr. Shaalan Beg: Yeah, and for what it's worth, I put up a Twitter poll asking my Twitter followers on how the BREAKWATER trial results will change their approach for newly diagnosed BRAF mutated colorectal cancer. We got 112 responses; 72% said that they will incorporate encorafenib, cetuximab, FOLFOX for their frontline BRAF mutated patients. But 23% said that they would like to wait for overall survival results. Dr. David Wang: Wow, that's interesting. They really want that 1x10 to the -8. Dr. Shaalan Beg: I guess so. All right. Let's change gears and talk about esophageal cancer. LBA329 was the SCIENCE study which presented preliminary results from a randomized phase 3 trial comparing sintilimab and chemoradiotherapy plus sintilimab versus chemoradiotherapy for neoadjuvant resectable locally advanced squamous esophageal cancer. Where are we in this space? Dr. David Wang: Okay. So, yeah, this was an interesting trial. Again, just to set the context, esophageal squamous cell carcinoma is more prevalent in Asia. And the study sites as well as the patients were mostly from Asia. So this was again a phase 3 trial with interim results. They only rolled 146 out of the planned 420 for this interim analysis. And yeah, they're using immune checkpoint inhibitor that we don't use in the United States, sintilimab, combined with their two standards of neoadjuvant therapy, either chemotherapy, which is more common in Asia, or or chemoradiation, which is more common in the US and Western Europe, versus chemoradiation. And so they actually had two primary endpoints, but only were reporting one. So their two primary endpoints were pathCR and the other one was event-free survival. The event-free survival, again, was not reported at the meeting.  What they found was that in terms of pathCR rate, if you take the two arms that are really informative about that, chemoradiation plus sintilimab versus chemoradiation alone, the pathCR rate was 60% versus 47%. We know that chemo alone doesn't induce as much of a pathCR rate, and that was 13%. So it was found that the delta in terms of pathCR between the chemoradiation arms, one with sintilimab and one without, was significant. And this actually confirms data again from Asia, like for the ESCORT-NEO trial where it used another immune checkpoint inhibitor pembrolizumab in addition to neoadjuvant chemo.  So as our discussant for this abstract said, yes, we know that radiation combined with chemotherapy improves pathCR rates, but we have recent data from the ESOPEC trial, we don't know that that necessarily will translate to overall survival. So again, waiting for additional enrollments and longer term follow up before incorporating this into clinical care here. Dr. Shaalan Beg: So David, how do the results of the SCIENCE trial compare with our practice in the United States and ongoing studies asking questions for neoadjuvant therapy for esophageal carcinoma in the United States? Dr. David Wang: I think obviously immune checkpoint inhibitor in the new adjuvant setting is important. Jennifer Eads at UPenn is running that EA2174 which is looking at chemoradiation plus or minus nivolumab, and then in non-pathCR responders randomized to adjuvant nivolumab per CheckMate 577 or nivolumab with intensification adding ipilimumab. We know that the ESOPEC trial just came out, and was published actually during the meeting, and that really focuses on adenocarcinomas. So adenocarcinomas of the GE junction, distal esophagus, now, we would probably treat very similarly to gastric using perioperative FLOT. However, the standard in the US for esophageal squamous cell carcinoma remains neoadjuvant chemoradiation. We know that squamous cell carcinomas are more exquisitely sensitive to radiotherapy. And then obviously in those patients who don't achieve a pathologic complete response, the expectation would be that they would go on to receive nivolumab per CheckMate 577. Again, the thought is that these tumors are more sensitive to immunotherapy given their higher incidences of mutational changes. And so again, this kind of goes along with the positive results seen in the SCIENCE trial that we just discussed with sintilimab but also EFFECT-neo with pembrolizumab. Obviously, we await the results of Jennifer's trial. Dr. Shaalan Beg: And the last abstract I was hoping we could get your perspective on was Abstract 652, which is a Phase 3 study of everolimus plus lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumors, the STARTER-NET trial. What were the results of this study? Dr. David Wang: So, I just want to give a shout out because we did have a session at this year's GI ASCO that looked at more rare tumors. So appendiceal tumors, neuroendocrine tumors, those kinds of things. So again, I would encourage your listeners to listen to that session if they have interest in that. Another type of rare tumor was adenosquamous tumors.  But in terms of the STARTER-NET trial, this was again an interim analysis of his phase 3trial and it was looking at combining everolimus plus lanreotide versus everolimus. So we know that in pancreatic-gastric neuroendocrine tumors, if you have low Ki-67, a well differentiated tumor, that the standard of care really is a somatostatin analog, and sometimes if they're more aggressive, we kind of consider molecular targeted therapy with everolimus. This was asking the question of whether we should do the combination on the frontline. And what was interesting is in this study, the patients were actually more of a poor prognostic set. So they had Ki-67 up to 20% or these were patients that actually had multiple liver lesions. And what they found was a median for progression free survival was improved with a combination out to 29.7 months versus 11.5 months with the somatostatin analog alone, and that the overall response rate was 23% versus 8.3%, again, favoring the combination. If you looked at subgroup analysis, it was actually those patients who had Ki-67 greater than 10%, so the more aggressive tumors, or those with diffuse liver lesions that had the most benefit. So I think that would be the patient population I would consider this new combination with using would be those patients again with poorer prognosis neuroendocrine tumor phenotype. Dr. Shaalan Beg: Thank you very much, Dr. Wang, for sharing your insights with us today and your great work to build a robust GI Cancers Symposium this year. Dr. David Wang: Well, thank you. I mean that really is a cooperative effort. We appreciate all the members of the GI25 Program Committee as well as the ASCO staff that just made it an outstanding meeting. Dr. Shaalan Beg: And thank you to all our listeners for your time today. You'll find links to the abstracts discussed today on the transcript of this episode.  Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:  Dr. Shaalan Beg @ShaalanBeg  Dr. David Wang Follow ASCO on social media:   @ASCO on Twitter  @ASCO on BlueSky ASCO on Facebook   ASCO on LinkedIn   Disclosures:  Dr. Shaalan Beg:  Employment: Science 37  Consulting or Advisory Role: Ipsen, Array BioPharma, AstraZeneca/MedImmune, Cancer Commons, Legend Biotech, Foundation Medicine  Research Funding (Inst.): Bristol-Myers Squibb, AstraZeneca/MedImmune, Merck Serono, Five Prime Therapeutics, MedImmune, Genentech, Immunesensor, Tolero Pharmaceuticals  Dr. David Wang: Honoraria:  Novartis Consulting or Advisory Role: Novartis, Cardinal Health, Bristol-Myers Squibb, BeiGene, Eisai  

David Wang, Professor at the Virginia Tech Dept. of Economics and former Credit Suisse Head of APAC (ex-Japan)Economics, joins us to discuss deflationary risks in the Chinese economy and whether the recent policy stimulus can address these pressures.(00:00) - Introduction (01:31) - China's Economic Prospects (05:10) - Drivers of deflationary pressures (08:37) - Expectations for household confidence (11:11) - New productive forces and labour productivity (15:46) - Assessment of Recent Policy Actions (17:37) - Fiscal Support and Consumption Policies (26:16) - Risks of a deflationary spiral (29:09) - High Leverage and deflation (32:12) - Outro

Why should investors care about volatility and how can it be used to inform investment decisions? On this episode, host Matthew Schnurr and Dustin Reid are joined by David Wang, FX Volatility Strategist at TD Securities, to discuss the importance of volatility in financial markets, its role as a form of financial insurance, and its influence on asset allocation decisions. David also explores volatility in the FX market and how recent political events have influenced volatility. This episode was recorded on June 27, 2024.

Reflecting on the book of Hosea, David Wang preaches a message on God's love and on a healing journey which holds both brokenness and beauty. David C. Wang is Cliff and Joyce Penner Chair for the Formation of Emotionally Healthy Leaders and associate professor of psychology. Recorded at Fuller's All-Seminary Chapel on February 14, 2024.  

Can you deliver medical treatment by changing brainwaves instead of injecting drugs? Elon Musk has recently implanted his first Neuralink into a human patient. But can we get neurotech medical treatment without drilling holes in our skulls? Maybe ... According to Element, a startup with roots in MIT, we can. And they say they can read your brainwaves, manipulate them, and fix issues like sleep disorders, tremors, pain, as well as speeding up learning.  Today we're chatting with Meredith Perry, the CEO and former NASA astrobiology Researcher, plus Dr. David Wang, co-founder and CTO, who has a PhD in AI from MIT. This technology could potentially treat medical conditions ranging from sleep disorders and tremors to learning difficulties. We also discuss the future of medtech, envisioning an 'app store for the brain' where individualized treatments can be downloaded like apps, focusing on promoting the most optimized state of health for any given individual through real-time detection and diagnosis. 00:00 Intro to Neurotech and Neurostimulation 00:33 Welcome and Introduction of Guests 01:31 Understanding the Concept of Elemind's Neurotech Device 02:59 Exploring the Form Factor of the Device 04:23 How it works 07:28 Effectiveness and Impact of the Device 13:05 Future Plans and Vision for the Device 18:52 Potential and Impact of the Device on Healthcare 21:35 Conclusion and Final Thoughts

This is a MUST LISTEN episode of The Sonography Lounge, hosted by Lori Green and Trisha Reo where we dive into a high-level discussion on various regenerative medicine options, and unveil the pivotal role ultrasound plays in musculoskeletal (MSK) injury diagnosis and treatment. This episode is for both healthcare providers and patients interested in Regenerative medicine treatment options. We discuss Prolotherapy, Platelet Rich Plasma (PRP), Adipose Derived Stem Cells, and Bone Marrow concentrate. This episode focuses mostly on Prolotherapy and PRP. Due to Time constraints, we will be doing follow up episodes on Adipose Derived Stem Cells (aka Lipoaspirate), and Bone Marrow Aspirate.   Joining us today are distinguished experts: Dr. John Broussard, (https://www.thealliancerx.com/) is board certified in Family Medicine and Sports Medicine and specializes in both regenerative and osteopathic manipulative medicine. He earned his Doctor of Osteopathic Medicine degree from Nova Southeastern University in South Florida and completed his residency training in Family Medicine at an osteopathic hospital, practicing in the urgent care setting. He then followed to complete a Sports Medicine Fellowship at the Institute for Non-Surgical Orthopedics in Florida. In 2014, he integrated ultrasound into his practice for diagnostics and guided interventional procedures. In 2020, he and his brother opened their own practice right here in sunny St. Pete. Together, they help active adults and athletes quickly overcome injury and get back to the activities they love. Dr. David Wang, (https://www.rosm.org/) Who earned his Doctor of Osteopathic Medicine degree from The West Virginia School of Osteopathic Medicine, where he was selected as a teaching Fellow in Osteopathic Manipulative Medicine. He completed his residency training in Physical Medicine and Rehabilitation at Harvard Medical School/Spaulding Rehabilitation Hospital, during which time he was appointed Chief Resident.  He is a founding partner and Director of Education and Training of Regenerative Orthopedics and Sports Medicine, with offices throughout the Metropolitan DC area.  He specializes in diagnostic musculoskeletal ultrasound, non-fluoroscopic interventional spine, osteopathic manual treatment, and regenerative medicine including prolotherapy, PRP, orthobiologics, and lipoaspirate stem cell therapies.    Dr. Imran Siddiqui, (https://www.rosm.org/) Currently serves as a Partner and the Director of Clinical Operations at Regenerative Orthopedics and Sports Medicine in Washington, DC.  He graduated medical school Cum Laude from Thomas Jefferson University where he was inducted in to the Alpha Omega Alpha honor society.  After which, he completed his residency at Harvard Medical School and Spaulding Rehabilitation Hospital where he trained extensively in musculoskeletal ultrasound and regenerative medicine and was awarded resident teacher of the year. Currently, Dr. Siddiqui also servers as an ultrasound and instructor and board member for the Interventional Orthobiologic Foundation.  He also has instructed at Harvard Medical School, Orthosound Educational Institute, and the American Academy of PM&R.   MSK ULTRASOUND RESOURCES   CME and Cross training resources: Gulfcoast Ultrasound Institute (Training materials and programs):https://www.gcus.com/   Certification Agencies: American Board of Emergency Medicine (ABEM): https://www.abem.org/public Sonographer / Physician: American Registry of Diagnostic Medical Sonography (ARDMS):http://www.ardms.org/ Physicians: Alliance for Physician Certification & Advancement (APCA):http://www.apca.org/ Point of Care Healthcare Providers: Point of Care Certification Academy (POCUS):http://www.pocus.org/ Sonographer / Physician: Cardiovascular Credentialing International (CCI):http://www.cci-online.org/  Find an accredited long term Ultrasound Program: https://www.caahep.org/Students/Find-a-Program.aspx

This episode features conversations with 3D InCites members who attended or exhibited at SEMICON Europa 2023, which took place in Munich, Germany from November 14-17, 2023. The topic of the week was Shaping a Sustainable $Trillion Era. Members weigh in on what their companies are doing to support this effort. They also discuss their impression of the show, what they were showcasing, and their latest news. Peter Dijkstra, Trymax Semiconductor, updates us on activities at Trymax USA and shares news of his participation at a Dutch and Flemish delegation in Phoenix Arizona in early December. Mike Motherway, Cimetrix by PDF Solutions, talks about the role cloud-native data tools for AI applications play in global fab expansion. Debbie Claire Sanchez at ERS Electronic explains the company's partnership with PulseForge to bring photonic debonding to their product portfolio as an equipment integrator of this technology. David Wang and Jim Straus of ACM Research share the news of the company's expansions in Asia as well as the Grand Opening of its new office in Portland, Oregon. Hans Peters and Emerald Grieg, PTW Group,  introduce a new tool line, SpinTec, established to renew and restore legacy SEZ single wet wafer tools.  Abul Lateef, PlasmaTherm, talks about the company's latest acquisition of Milan-based Thin Film Equipment, to complete PlasmaTherm's sputtering and PVD portfolio, and put them near significant customers in Italy.  Neil O'Brien, Finetech, talks about the growing need for high-accuracy die-bonders, and how that's driving a need for full production tools based on its tabletop machines originally developed for academia.  Harald Eppinger, Koh Young Europe, explains how the company's 3D optical measurement tools deliver precise data that helps to visualize advanced packaging processes to improve quality and reduce failures.  Dieter Rathai, DR Yield,  shares some feedback from the Fab Manager Forum and how he uses that information to inform his business and improve his company's product. Spencer Wall, Jeroen Haex, and Michael Murray, of DSV Solutions explain the role a logistics service provider can play in shaping a sustainable $Trillion Era through inventory and supply chain strategies, as well as a commitment to certified alternative fuels for all modes of transport.  Support the showBecome a sustaining member! Like what you hear? Follow us on LinkedIn and TwitterInterested in reaching a qualified audience of microelectronics industry decision-makers? Invest in host-read advertisements, and promote your company in upcoming episodes. Contact Françoise von Trapp to learn more. Interested in becoming a sponsor of the 3D InCites Podcast? Check out our 2023 Media Kit. Learn more about the 3D InCites Community and how you can become more involved.

This episode of “The Standard Formula” podcast launches the “Back to Basics” series, which will comprehensively cover the U.K.'s Solvency II regime. For the premiere episode, Skadden partner Rob Chaplin and associate David Wang delve into the intricacies of own funds, a core concept of Solvency II.Own funds constitute an insurer's regulatory capital, comprising both balance sheet and limited off-balance sheet items. This discussion covers the three classification categories for own funds: Tier 1 (highest quality), Tier 2 (middle) and Tier 3 (broader spectrum and flexibility). Mr. Chaplin and Mr. Wang outline the specific requirements for each tier. Two characteristics of own funds fundamental to understanding them, namely permanent availability and subordination, are explored in detail.The episode also includes a discussion of regulatory approvals and notifications and the implications of these concepts on the Lloyd's Insurance Market.

Dr. David Wang is a licensed psychologist and associate professor of psychology and pastoral counseling at the Rosemead School of Psychology, at Biola University. He is the editor of the Journal of Psychology and Theology and serves on the editorial board for Spirituality in Clinical Practice (an APA journal). He also leads research funded by the John Templeton Foundation and the Lilly Foundation investigating the spiritual and character/virtue development of seminary students. Dr. Wang teaches and speaks internationally, maintains a small clinical practice in Fullerton, CA and is the pastor of spiritual formation at One Life City Church

Dave and Jason answer your questions and get sentimental with friends writing in to congratulate, speculate and inquire about the show, the state of the DC films and television, and what DC on SCREEN means to them:Giuseppe Vicaretti wants to know if water is indeed wet.David Wang requests a Zack Snyder's Justice League Commentary episode!Donny Hollingsworth offers his praise for the show!Lou Lanza loves the show and Dave's voice DOES NOT put him to sleep!Denton Trotter enjoys the show and it makes him feel like he did talking comics with friends.Andre' Sparks wants to know who are two characters we'd love to see together in live action for the first time!Chris Balga asks about our favorite show moments, what one thing we would change about DCU, what DC film would be go back and watch for the first time, what the most ridiculous thing is that's happened in 700 episodes, and who are favorite comic book creative team is!David Fatta enjoys the podcast and loves silver age comics.Brentacprime is kindly in awe of our accomplishments.Andre' Sparks asks if we've seen Justice League x RWBY part 1Amy Henry would like to know what kind of animal we'd be if we could. And also if we think there are aliens.Effie Ophelders chokes Dave up with kind words, then wonders what we think the unannounced DCU Chapter 1 projects are.An Ad for Dove's Gaming Twitch StreamDerek J fills our fuel tank for more podcastings while showing us his geek roots.Kieran Ridgeway asks which DC villain we'd want to play and who we're looking forward to seeing the most in Creature Commandos!Baxter needs comic recommendations and wants to be our video game correspondent!Eli Hernandez wonders why Batman doesn't dance anymore.JD McRae asks what we're more excited for in the new DCU.Pud333 wants to know who our most awesome listener is!Widder Woman loves her DC on SCREEN and corn squeezin's!Tuddle D. Tuttle has been lurking.Join our riotous DC debauchSite: https://dconscreen.comStore: https://bit.ly/DCoStorePatreon: https://patreon.com/dconscreenApple: http://bit.ly/DCoSReviewSpotify: http://bit.ly/DCSCREENSpreaker: https://bit.ly/DCoSSpreaker"Magic Escape Room" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 Licensehttp://creativecommons.org/licenses/by/4.0/"Full On" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 Licensehttp://creativecommons.org/licenses/by/4.0/This show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/3414609/advertisement

With all the conversations on recent advancements in technology, particularly generative AI, we thought we'd revisit our interview with David Wang, chief innovation officer at Wilson Sonsini Goodrich & Rosati. His career exemplifies the importance of tech innovation and change management in the legal profession. We hope you enjoy. We will return with a new episode next week. The past few years have seen a rise in heads of innovation at Big Law firms. One of the leading voices in this space is David Wang, Wilson Sonsini Goodrich & Rosati's chief innovation officer. David is responsible for overseeing the firm's innovation strategy, the development and implementation of legal technology programs, and supporting and advising both internal and client teams on the legal and operational implications of emerging technologies and business models. He previously practiced corporate and securities law for more than 10 years, working with private and public companies on general corporate and transactional matters. Prior to becoming a lawyer, David was an entrepreneur himself. Under David's leadership, Wilson has received multiple accolades for their innovative use of technology. In this episode, we discuss how David transitioned from the practice of law to leading a cutting-edge innovation and technology team at a Big Law firm, how he manages his portfolio of responsibilities, his decision-making process for taking on new projects, and what excites him most in the legal tech market.

Join us in this episode as we delve into the remarkable journey of David Wang, Chief Innovation Officer at Wilson Sonsini, as he navigates the challenges of defining his role in the legal industry. From humble immigrant beginnings and his mother's Chinese restaurant, David's path has led him to become one of the pioneering chief innovation officers in the legal field. In this captivating conversation, David shares his insights on the crucial role of a CINO and the profound impact of NextGEN technology on the business of law. As he eloquently explains, while the larger law firms may weather the storm, the rest of the industry will undoubtedly be influenced, and some firms will seize the opportunity to leverage technology, offering innovative value propositions and pioneering new business models. Delving deeper, we explore how corporate law departments are emerging as the true disruptors in the legal market, thanks to advancements in technology. David reveals how these departments are empowered by technology to undertake tasks previously deemed unattainable and how they are able to hire talent at a more junior level, revolutionizing the legal landscape. Tune in to this inspiring episode as we uncover the remarkable story of David Wang and gain valuable insights into the evolving world of legal innovation and the boundless possibilities that lie ahead. For more on Cowen Podcasts, Career Coaching, and Leadership Networking Events, please visit www.Cowengroup.com

Se o Em Suma é sobre conexões improváveis, é talvez difícil de encontrar algo tão contrastante quanto um místico católico romano e um pastor puritano. Porém, hoje veremos como ambos nos ajudariam a tratar um problema espiritual sério: o que fazer quando paramos de sentir a presença de Deus? E a resposta deles é que é uma feature e não um bug. Ou seja, a luz de Deus se vê melhor à noite. Venha aprender com esses mestres da espiritualidade no episódio de hoje. Veja uma transcrição deste episódio em nosso ⁠⁠blog.⁠⁠ Na Pilgrim você também pode ler uma boa análise dos pressupostos filosóficos por trás da obra de S. João da Cruz. Se você gostou deste episodio, compartilhe o Em Suma, um produto gratuito da Pilgrim, para que possamos continuar financiando este trabalho. _____ PARA SE APROFUNDAR S. João da Cruz. Obras Completas. Rowan Williams. Open to Judgement. Joseph Symonds. The Case and Cure of a Deserted Soul. David Wang. “Two Perspectives on Spiritual Dryness: Spiritual Desertion and the Dark Night of the Soul”. Journal of spiritual formation & soul care, 4(1), 2011, 27-42. Joel Beeke e Mark Jones. Teologia puritana. Jason Baxter. Introduction to Christian Mysticism. _____ JÁ CONHECE A PILGRIM? A nossa plataforma oferece acesso a conteúdos cristãos de qualidade no formato que você preferir. Na Pilgrim você encontra audiolivros, ebooks, palestras, resumos, livros impressos e artigos para cada momento do seu dia e da sua vida: https://thepilgrim.com.br/ _____ SEJA PILGRIM PREMIUM Seja um assinante da Pilgrim e tenha acesso a mais de 10.000 livros, cursos, artigos e muito mais em uma única assinatura mensal: https://thepilgrim.com.br/seja-um-assinante Quais as vantagens? Acesso aos originais Pilgrim + Download ilimitado para ouvir offline + Acesso a mais de 10.000 títulos! + Frete grátis na compra de livros impressos em nossa loja _____ SIGA A PILGRIM No Instagram: https://www.instagram.com/pilgrim.app/ no Twitter: https://twitter.com/AppPilgrim no TikTok: https://www.tiktok.com/@pilgrimapp e no YouTube: https://www.youtube.com/channel/UCy1lBN2eNOdL_dJtKnQZlCw Entre em contato através do contato@thepilgrim.com.br. Em suma é um podcast original Pilgrim. Todos os direitos reservados. O ponto de vista deste texto é de responsabilidade de seu(s) autor(es) e colaboradores diretos, não refletindo necessariamente a posição da Pilgrim ou de sua equipe de profissionais. _____ SIGA-ME NAS REDES SOCIAIS No Instagram: https://www.instagram.com/theolo.gui/ No Twitter: https://twitter.com/GCPdf

The Sonography lounge is happy to be joined by Dr. Jon Jacobson and Dr. David Wang, two wild and crazy guys and masters of musculoskeletal ultrasound who are leading the way in this consistently growing industry. This episode is taking place as part of our Happy Hour series, winding down from a long day with a drink, casual banter,  and questions to get to know each other. Dr. Jacobson is a Musculoskeletal Radiologist with Lenox Hill Radiology in New York, NY. Dr. Jacobson earned his RMSK credential in 2012 from the American Registry of Diagnostic Medical Sonography. He has published over 250 manuscript publications and has authored numerous book chapters as well as completing his 3rd edition of the textbook “Fundamentals of Musculoskeletal Ultrasound.”  He lectures extensively throughout the United States and internationally and we have had the pleasure of working with him for many years. Dr. David Wang earned his Doctor of Osteopathic Medicine degree from The West Virginia School of Osteopathic Medicine, where he was selected as a teaching Fellow in Osteopathic Manipulative Medicine. He completed his residency training in Physical Medicine and Rehabilitation at Harvard Medical School/Spaulding Rehabilitation Hospital, during which time he was appointed Chief Resident.    He is a founding partner and Director of Education and Training of Regenerative Orthopedics and Sports Medicine, with offices throughout the Metropolitan DC area.  He specializes in diagnostic musculoskeletal ultrasound, non-fluoroscopic interventional spine, osteopathic manual treatment, and regenerative medicine including prolotherapy, PRP, orthobiologics, and lipoaspirate stem cell therapies.     Dr. Wang has been actively teaching regenerative medicine nationally and internationally since 2008, including over 20 intensive prolotherapy training medical missions in Honduras, Mexico and Greece.     Upcoming MSK Ultrasound Courses and Products   The Sonography Lounge: https://thesonographylounge.podbean.com/   Gulfcoast Ultrasound Institute (Training materials and programs): www.gcus.com   Certification Agencies: American Board of Emergency Medicine (ABEM): https://www.abem.org/public Sonographer / Physician: American Registry of Diagnostic Medical Sonography (ARDMS): www.ardms.org Physicians: Alliance for Physician Certification & Advancement (APCA): www.APCA.org Point of Care Healthcare Providers: Point of Care Certification Academy (POCUS): www.pocus.org Sonographer / Physician: Cardiovascular Credentialing International (CCI): www.cci-online.org   Find an accredited long term Ultrasound Program: https://www.caahep.org/Students/Find-a-Program.aspx  

As the manufacturing world adopts next generation Industrial 4.0 platforms and tools, CEO David Wang explains how BEET's industry leading software digitizes every manufacturing motion and simplifies complex factory systems to visualize bottlenecks, maximize throughput and unlock potential. Hear from David Wang as he discusses his path to America and the journey taken to create this successful software engineering firm. With over a decade of experience in the automation industry, Michigan-based BEET helps companies understand and address constraints in their manufacturing processes and has revolutionized plant floor visibility and the pathways to greater factory efficiency. Founded and grown in the heart of the automotive capital of the world, BEET has become a market leading tool in the transition to smart factories. 

Anand Buch, invited by David Wang in the founding of NetSapiens in 2002, is among those ‘present at the creation' of the cloud communications market. Today, what was invented by NetSapiens, sits at the heart of Crexendo, where Buch serves as Chief Strategy Officer and Co-Founder. “There's a ton of rapid acceleration going on,” observes Buch as Enterprise Connect was clearly looking to AI as the next chapter in the story of how people and organizations communicate. In this podcast, Buch tells us how Crexendo, providing communications, collaboration and contact center solutions for providers, remains focused on delivering CX. “Customer experience is the key,” says Buch. Crexendo has recently passed the three million user milestone and is growing faster than the market. Visit www.crexendo.com  

Dr. David Wang, Associate Professor of Psychology at Fuller Seminary, joins Benita and Jackie for an in-depth exploration on the definition and practice of spiritual formation and soul care.Mosaic: Theology & Theologising in Asia and beyond

  David Wang is the Chief Innovation Officer at Wilson Sonsini, and is the only person of color and Asian American on the management team.   According to a Yale Law School report published in November 2022, Asian Americans are the largest minority group at major law firms, but continue to have the lowest ratio of partners to associates (only 4.3% are equity partners).    So how does one break the bamboo ceiling?  In this episode, we discuss:   - Difficult conversations about how you can break the bamboo ceiling. - How a serendipitous meeting can change the course of your career and lead you on a career path you never thought of.   - Why fortune favors the prepared, and what you can do to make sure that when the opportunity arises, you can capitalize on it.   - How what may be perceived as a weakness can be your X factor that leads to your unique value.   - How to create small wins, so that you can get buy-in even from those who are skeptical.   - What you can do as a leader to give your team a sense of belonging and to change policies that help to dismantle systemic discrimination.  Connect with David on LinkedIn at www.linkedin.com/in/david-y-wang.   Connect with Samorn at www.linkedin.com/in/samornselim.   Get a copy of Samorn's book, “Belonging: Self Love Lessons From A Workaholic Depressed Insomniac Lawyer” at https://tinyurl.com/swpc578c.      Get weekly career tips by signing up for our newsletter at www.careerunicorns.com.  

Most of us who have served in various ministry capacities (e.g., as pastors, missionaries, lay church leaders, etc.…) are intimately familiar with the potential dark realities of the ministry environment. Empirical research confirms that ministry is indeed often a difficult endeavor, imposing significant stress upon our spiritual life, our marital and family relationships, and our own emotional and physical well-being. Often, those who need counseling and care the most are Christian leaders who, over the course of their ministry journey, have been deeply wounded by fellow Christians, finding themselves now downtrodden, burnt out, isolated, misjudged, and discouraged. In such cases, how does one go about engaging the process of healing? This workshop will present practical and research-informed considerations and recommendations in the care of Christian leaders who have been emotionally wounded by the ministry context, with special attention placed on the experiences of Asian-American church leaders. --- Send in a voice message: https://podcasters.spotify.com/pod/show/ptscaac/message

On today's episode, we're joined by David Wang, VP of Product Marketing at Imply and Muthu Lalapet, Director of Worldwide Sales Engineering at Imply to dig into Apache Druid, a high performance, real-time analytics database. Thousands of companies are already using Druid today, from Netflix to Salesforce. But what is Apache Druid best used for? What types of projects? What data sets are Druid users working with? What are companies doing with Druid?  Listen to hear real-life examples of where Druid works best: Operational visibility at scale, customer-facing analytics, rapid-drill down exploration and real-time decisioning.

Dr. David Wang is a licensed psychologist and associate professor of psychology and pastoral counseling at the Rosemead School of Psychology, at Biola University. He is the editor of the Journal of Psychology and Theology and serves on the editorial board for Spirituality in Clinical Practice (an APA journal). He also leads research funded by the John Templeton Foundation and the Lilly Foundation investigating the spiritual and character/virtue development of seminary students. Dr. Wang teaches and speaks internationally, maintains a small clinical practice in Fullerton, CA and is the pastor of spiritual formation at One Life City Church    

David Wang (https://www.linkedin.com/in/theprofitableside) is joining Smashnotes team to lead our community and advertising efforts. Here David explains what we want to achieve, and how you could get involved. If you have any questions, shoot him an email david@smashnotes.com

Quincy artist David Wang chats about his background, education, experience, and inspiration as he prepares to co-exhibit at the QArts Gallery a show called Roads Well Traveled with Photographer Alice Donaldson.

This episode features Dr. David Wang, Co-Director of the Neurovascular Division & Petznick Stroke Center at Barrow Neurological Institute; Dr. Robert Lemery, Cardiac Electrophysiologist at Arizona Heart Rhythm Center; & Dr. Vijay Swarup, Director of Cardiac Electrophysiology at Arizona Heart Rhythm Center & Director of Electrophysiology at St. Joseph's Hospital. Here, they discuss details surrounding their collaborative work with The Arizona Brain and Heart Symposium taking place October 21st & 22nd, 2022. Learn more at https://www.barrowneuro.org/patient-care/support-resources/education-seminars/the-arizona-brain-and-heart-symposium/

Years ago, there were precious few choices for database technology. You had IBM, Oracle, SAP, and some stuff from a Microsoft company. Today, there are hundreds of database technologies to choose from, each of them designed for a particular purpose. What's the latest? Check out this episode of DM Radio to find out as host @eric_kavanagh will interview guests, including Keshav Pingali, Katana Graph; David Wang, Imply; and Jim Walker, Cockroach Labs.

David Wang's web site is http://www.davidforcouncil.ca ----------- ABOUT THIS SERIES: This municipal election cycle, I asked each of the candidates for mayor, council, and school district, to record a bit about themselves, why they decided to run, and their platforms. This is offered as a public service to the community; candidates did not have to pay a fee to participate. Produced by Tod Maffin of engageQ digital. Theme song: "Make a Change" (composed by Tom Howe and Dan Gautreau). Music licensed through Source Audio.

The past few years have seen a rise in heads of innovation at Big Law firms. One of the leading voices in this space is David Wang, Wilson Sonsini Goodrich & Rosati's chief innovation officer. David is responsible for overseeing the firm's innovation strategy, the development and implementation of legal technology programs, and supporting and advising both internal and client teams on the legal and operational implications of emerging technologies and business models. He previously practiced corporate and securities law for more than 10 years, working with private and public companies on general corporate and transactional matters. Prior to becoming a lawyer, David was an entrepreneur himself. Under David's leadership, Wilson has received multiple accolades for their innovative use of technology. In today's conversation, we discuss how David transitioned from the practice of law to leading a cutting-edge innovation and technology team at a Big Law firm, how he manages his portfolio of responsibilities, his decision-making process for taking on new projects, and what excites him most in the legal tech market.

Years ago, there were precious few choices for database technology. You had IBM, Oracle, SAP, and some stuff from a company called Microsoft. Today? There are hundreds of database technologies to choose from, each of them designed for a particular purpose. What's the latest? Check out this episode of DM Radio to find out! Host @eric_kavanagh will interview several guests, including Keshav Pingali, Katana Graph; David Wang, Imply; and Jim Walker, Cockroach Labs.

How should Asian American Christian leaders deal with burnout? Raymond and Michelle join Dr. David Wang to talk about strategies for spiritual formation, social support, and more. Stay connected with the AACC Instagram/Facebook/Twitter: @aachristcollab https://asianamericanchristiancollaborative.com Credits Hosts: Raymond Chang, Michelle Reyes Sound engineers: Katie Nguyen, Sean Kim

In this season finale, our guest Dr. David Wang shares important and practical insight on trauma-informed ministry. Tune in to learn how youth leaders can care for themselves and walk alongside students who have experienced trauma. This episode is hosted by Giovanny Panginda and Roslyn Hernández and was inspired by SCARS - Trauma Informed Discipleship, a free video-based resource developed by our friends at UYWI. Sign up for the Fuller Youth Institute email list Related FYI resources:  Blog: Processing the Tragedy of School Shootings Blog: Supporting Young People When They're Suffering

Ischaemic stroke is a leading cause of morbidity and mortality. The World Health Organization defines stroke as “a clinical syndrome consisting of rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin”. David Wang, Professor of Neurology, Barrow Neurological Institute, Phoenix, Arizona, gives us a clinical overview of the condition. For more on ischaemic stroke, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/3000114 - The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner's judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Checkout XR General Hospital on Discord: https://discord.gg/xkwSXtzbF5Follow:@xrgeneralhospital@technically.a.nomad (David)Sponsors:@SkateKastle@Flatland3d - 10% off with the code "Electricskatecast"@Alter.BagsSupport the show (https://www.buymeacoffee.com/EskateCast)

David Wang is an Regional Sales Director and top leader in Arias Dlabik Agency.

This week, we learn all about the new Catholic show for tween-agers, Studio 3:16, and we talk about depression and mental health with Deacon Ed Shoener of the Association of Catholic Mental Health Ministers. We also meet singer/songwriter Katie Curtis, who has muscular dystrophy, and reconnect with David Wang from the band Critical Mass, whose new album, Serenity, deals with parental alienation.

Is Pope Francis coming to Canada next year? This week on the SLHour, Archbishop Richard Smith of Edmonton tells us all we know and how we got here. Danny Torchia returns to begin another season of media tips, Billy Chan has a question about the Mass and we learn about Parental Alienation with singer/songwriter David Wang of Critical Mass.

Is Pope Francis coming to Canada next year? This week on the SLHour, Archbishop Richard Smith of Edmonton tells us all we know and how we got here. Danny Torchia returns to begin another season of media tips, Billy Chan has a question about the Mass and we learn about Parental Alienation with singer/songwriter David Wang of Critical Mass.

Recent developments have served as a stark reminder that understanding the Chinese mindset is essential to successfully investing in China as a foreigner. Who better to unpack this topic in grave detail than Credit Suisse's Chief China Economist David Wang. David shares many helpful insights on the ongoing regulatory crackdown from a local perspective and provides a unifying framework for thinking about China's long-term policy goals. We hope you take away as much from our conversation with David as we did. Enjoy.   Join the HedgeD, With A Capital “D” webinar series by contacting us at HedgeD@morgancreekcap.com   Follow us on Twitter @HedgeD_Podcast   Visit us on the web at https://www.morgancreekcap.com/hedge-funds/

Mochipet - "Godzilla League of Legends" from the 2021 self-released album Godzilla Resurgence. David Wang has long had an obsession with dinosaurs, from wearing a purple costume of the prehistoric creatures in his musical alias of Mochipet, to the recent release of his EP Godzilla Resurgence, named for the mythical kaiju who has starred in films since the 1950s.  “I saw my first Godzilla movie when I was around 10 years old in Taiwan. I think my cousin showed it to me or something," Wang toldMixMag Asia late last year. “I actually didn't like it at first. I didn't understand why Godzilla was destroying Japan and I didn't like that it was in black and white. It was not till later in my life I began to appreciate Godzilla for its representation of the human need for control and the Atomic Bomb that devastated Hiroshima and Nagasaki and destroyed many lives during World War II. Godzilla is a constant reminder of man's need for control which usually ends in death and destruction." The new EP is dedicated to the memory of Wang's father, who passed away as this release was nearing completion. Proceeds are going towards the cost of his funeral and burial costs. More information here. Read the full post on KEXP.org Support the show: https://www.kexp.org/donate See omnystudio.com/listener for privacy information.

Episode Overview: The best way to solve an issue in society, is to finally admit that there is in fact an issue in society. We as women try in our ways to break down the barriers to entry, to be allowed to hold typically male-dominated roles, but for our guest today-- she's taken this as a life mission through her work. Dr. Amy Diehl is a professional in the Tech Industry, being the Chief Information Officer at Wilson College in Chambersburg, Pennsylvania. Listen in as Dr. Diehl walks us through her life and her fight against Gender Bias in the world-- particularly a scale she created with Dr. Amber Stephenson from Clarkson University, and Drs. Leanne Dzubinski and David Wang from Biola University that contain evaluations to identify the 6 Primary Factors of Gender Bias.   Episode Highlights:   Amy's life in college How she connected with other women from shared adversity in a male-dominated field How her female bosses became her mentors Her book on Gender Barriers after her dissertation 6 Primary Factors of Gender Bias that she identified   About Amy Diehl: Dr. Amy Diehl is an information technology leader who is currently the Associate Vice President and Chief Information Officer at Wilson College in Chambersburg, Pennsylvania Drawing from her own experience, she's published her doctoral dissertation focused on how women leaders in higher education make meaning of adversity, making her a woman in the field actively dedicated to dispelling gender bias in the workplace. In 2019, she was named a Central Penn Business Journal Woman of Influence and received the 2016 Women and Leadership Affinity Group Outstanding Scholarship for Emerging Scholars Aware from the International Leadership Association.   Connect with Amy:   Amy Diehl | LinkedIn Amy Diehl | Twitter Amy Diehl | Website   --- Did you enjoy today's episode? Please click here to leave a review for The 6%, with NancyMD. Be sure to subscribe to your favorite podcast app to get notified when a new episode comes out!    Do you know someone who might enjoy this episode? Share this episode to inspire and empower!   Let's get social! Instagram @_nancymd Facebook @nancymdpdx Twitter @_nancymd LinkedIn @nancyyenshipleymd Website www.nancymd.com   Subscribe to The 6%, with NancyMD ++ Apple Podcasts ++ Spotify ++ Google Podcasts

Data brokers are the major players in the market of collecting, selling, and sharing online user information. Although their practices have raised tremendous privacy concerns, their data collection and sharing activities are still under the veil. The growth of adverse cybersecurity incidents toward the data brokers has led the regulators, including California and Vermont, to require the data brokers to register and disclose their activities. This paper analyzes the leaked information on the dark web to analyze the data sharing and collection activities among the data brokers. In specific, we cluster the data brokers based on their data collection activities given by their product description to quantify the activity proximity. Next, we empirically examine how activity proximity leads to co-occurrence on the leaked information in the dark web. We further discuss the deterrence effect of the data broker registration on information leakage. Our study contributes to cybersecurity assurance and risk assessment literature by unveiling the shadowy data-collecting and data-sharing market. About the speaker: Tawei (David) Wang is currently an Associate Professor and Driehaus Fellow at DePaul University. He received his Ph.D. from Krannert Graduate School of Management, Purdue University in 2009. His research interests are information security management and IT management. His papers have appeared in several leading journals, including Information Systems Research, Decision Support Systems, European Journal of Information Systems, Information and Management, Information Systems Journal, Journal of Accounting and Public Policy, Journal of Banking and Finance, Journal of Information Systems, among others. His articles have been downloaded more than 40,000 times through Science Direct. He was a speaker at events hosted by the  Institute of Internal Auditors and Institute of Management Accountants, and a panelist in a cyber risk workshop hosted by the Federal Reserve Bank Charlotte. He was selected to be the KPMG James Marwick Professor in Residence in 2018.

Data brokers are the major players in the market of collecting, selling, and sharing online user information. Although their practices have raised tremendous privacy concerns, their data collection and sharing activities are still under the veil. The growth of adverse cybersecurity incidents toward the data brokers has led the regulators, including California and Vermont, to require the data brokers to register and disclose their activities. This paper analyzes the leaked information on the dark web to analyze the data sharing and collection activities among the data brokers. In specific, we cluster the data brokers based on their data collection activities given by their product description to quantify the activity proximity. Next, we empirically examine how activity proximity leads to co-occurrence on the leaked information in the dark web. We further discuss the deterrence effect of the data broker registration on information leakage. Our study contributes to cybersecurity assurance and risk assessment literature by unveiling the shadowy data-collecting and data-sharing market.

In this episode of the Second Success Podcast, Dr Rakish Rana talks with entrepreneur, David Wang. David Wang is a successful entrepreneur, consultant & strategic investor. He has a strong passion for tech startups and advises organizations on how to reshape digital business models. David has professional consulting experiences in managing digital transformation projects, strategy, M&A transactions & startup venture developments. He's already consulted on various digital transformation projects for international top tier clients and has advised Fortune 500 CxOs and senior executives in developing and executing technology strategies. Overall, he has a unique cross-cultural business understanding and has gained industry experiences in automotive, chemical, eCommerce , life science, logistics, insurance, reinsurance, public sector, and across startups. Besides his professional consulting career, David also has a strong focus on startups and venture development. He has conducted seed investments to various early-stage startups. Listen to how he made the switch from corporate to entrepreneur!! David Wang: https://www.thisiswang.com/ YouTube: https://www.youtube.com/thisiswang Instagram: https://www.instagram.com/theprincewang/ Episodes released every Tuesday 6am GMT. How can you support the podcast? 1. Share it on your social media platforms. 2. Tell your friends and family 3. Please follow, subscribe and review --- Send in a voice message: https://anchor.fm/theclearcoach/message

This week, Thomas and Nathan being to delve into one of the most insane lives in all of history that you've most likely never heard of: Gabriele D'Annunzio. From rockstar poet, to warmonger, to accidental proto-fascist, this maniac's life gives a dark new meaning to that old pick-me-up "All you need to do is believe in yourself."Contact us!podcast@ubcfizz.comSources for this episode:"The Pike: Gabrielle D'Annunzio, Poet, Seducer, and Preacher of War" by Lucy Hughes-Hallet. ISBN 978-0-00-721396-2"A Man of Many Parts: Gabriele D'Annunzio", from The Rake, written by Josh SimsWikipedia as a corroborator for basically every topic covered here.Thanks to David Wang for being our eternally humble editor.

I was joined by David Wang who leads product marketing in HPE Storage to look at the highlights of the year in HPE Storage. Despite many of the world events, it was an outstanding year in HPE Storage. David and I discussed awards, recognitions, and some of the product announcements that made 2020 a very good year for HPE Storage.

Dr. David Wang is a licensed psychologist, pastor, and associate professor of psychology and pastoral counseling. He teaches and speaks internationally, maintains a small private practice, and has been involved with non-profit organizations locally and internationally such as Joya Scholars (joyascholars.org) and International Justice Mission (ijm.org). Join us as we ask questions about what grief looks in our current Covid world, how grief impacts our mental health, and what gets in the way of grieving. In this episode, we explore themes of the meaning-making process, engaging spiritual communities, and supporting one another in difficult times.

Dr. David Wang is a licensed psychologist and associate professor of psychology and pastoral counseling at the Rosemead School of Psychology, at Biola University. He is the editor of the Journal of Psychology and Theology and serves on the editorial board for Spirituality in Clinical Practice (an APA journal). He also leads research funded by the John Templeton Foundation and the Lilly Foundation investigating the spiritual and character/virtue development of seminary students. Dr. Wang teaches and speaks internationally, maintains a small clinical practice in Fullerton, CA and is the pastor of spiritual formation at One Life City Church       https://www.drdavidcwang.com/about-dr-wang For Dr. Wang's sermons on Lament: https://www.onelifecitychurch.org/sermons   Online Small Groups Training

What is it about HCI that enterprise IT likes so much? On this episode David Wang, HPE's director of storage marketing, drops in to talk to hosts Matt Kimball and Steve McDowell about why HCI is compelling, and how the different flavors of HCI address a range of needs in the enterprise, whether on the edge or in the core. HPE is in an interesting place with HCI. The company has two in-house HCI solutions, dHCI and SimpliVity, and is a major mover of both Nutanix and Vmware VSAN software. How does HPE position them? And what's the right answer for your IT shop? Join us in a wide-ranging and fascinating conversation about HCI's place in the enterprise, and where HPE's dHCI and other solutions fit. A special thank you to Sonal Dave' for helping out with the logistics and, of course, David Wang for joining us! Special Guest: David Wang.

#014 - Join host Dr. Red Hoffman as she interviews Drs. Kate Aberger and David Wang, emergency medicine physicians who specialize in palliative care.  They are the editors of the recently released book, "Palliative Skills for Frontline Physicians," a collection of case-based vignettes which illustrate how to practically integrate palliative care into all fields of medicine, including surgery, emergency medicine, internal medicine and critical care, among others.  David and Kate discuss how to successfully integrate palliative medicine into the care of emergency room patients, the forces that make this integration difficult and the reality that this work cannot be done without the support of hospital administration.  Kate talks about her palliative care work during the COVID epidemic in New Jersey and David shares research conducted at his institution which showed that palliative care consults placed by ED physicians at admission resulted in decreased length of stay and lower overall hospital costs for patients.   Join us for another inspiring episode that proves that palliative medicine can be utilized successfully throughout the hospital, even in the basement (where it seems many EDs are located!). To learn more about the recently released Palliative Skills for Frontline Physicians, click here. To learn more about palliative care in the emergency department read this article by Dr. Wang.  To learn more about the surgical palliative care community, visit us on twitter @surgpallcare.

The Church of the future must be trauma-informed. The World Health Organization has found that approximately 70% of individuals worldwide have been exposed to some type of traumatic event in their lifetime. This figure is even more pronounced in urban populations. In fact, one study found that nearly 90% of individuals who reside in low-income urban areas have experienced many types and combinations of trauma. With this evidence, church leaders must operate from a place of healing. You can't give what you don't have. When church leaders are operating from unresolved trauma, it is possible to do more harm than good. We must address these underlining issues as leaders. Episode 3, featuring Dr. David Wang, is an invitation to deep healing. Dr. Wang is a licensed psychologist, pastor, and associate professor of psychology and pastoral counseling. He is also the editor of the Journal of Psychology and Theology and serves on the editorial board for Spirituality in Clinical Practice (an APA journal).Support the show (https://interland3.donorperfect.net/weblink/WebLink.aspx?name=E12333&id=12)

It seems almost every day brings a new finding about COVID-19, but still, relatively little is understood about the novel coronavirus, the disease it causes or how best to prevent and treat it. Scientific research takes time, but the lack of sound research hasn’t stopped some from filling in the gaps with their own theories about the origins of the virus, potential treatments, vaccines, the usefulness of masks and other matters. In this episode, we discuss some of the strange theories filling social media feeds and even climbing best-seller lists. David Wang, PhD, a professor of molecular microbiology, and of pathology and immunology, discusses the origins of the new coronavirus, as well as what can be learned from past outbreaks. In addition, Michael S. Kinch, PhD, associate vice chancellor and director of the Center for Research Innovation in Biotechnology and the Center for Drug Discovery, discusses fears, particularly fears and rumors often linked to vaccines. Also a professor of radiation oncology and of biochemistry and molecular biophysics, he authored the book “Between Hope and Fear,” about the history of vaccines in medicine. The podcast, “Show Me the Science,” is produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis.

In this week's episode, we talk with a panel of palliative care experts - Drs. Rebecca Goett, Sangeeta Lamba, and David Wang. They discuss providing the highest quality care for your patients during the COVID crisis. They also remind us of the importance of our own mental health.

Dr. Victor Nauffal, cardiology fellow at Brigham and Women's Hospital, is interviewed by Dr. David Wang about tachyarrhythmias. They work through a case and general approach to this topic, including a discussion about when to use electricity, distinguishing rhythms on an EKG, and treatment considerations. The case concludes with clinical pearls to take with you on the wards. https://www.runthelistpodcast.com/cardiology/#tachyarrhythmias Episode handout available here: http://bit.ly/RTL_tachyarrhythmias

Do you join Tzu Chi because you are told to do so, or because you yourself want to be in Tzu Chi? David has them both, and shares what makes it click for him to join Tzu Chi wholeheartedly.

Today on ACEP Frontline Dr Ryan Stanton talks with his guest Dr. David Wang about Palliative Care and how to have difficult conversations with patients and their loved ones. For more resources, please visit ACEP's Palliative Care page: https://www.acep.org/by-medical-focus/palliative-medicine/

Shelley and I work as rival shipping conglomerates in South Asia in East Indiaman by David Wang from David Wang Studio then get more contemplative with the beautiful garden-building game Horticulture Master by Lin Yen-Kuang from MOZI Game

Welcome to the second podcast in the run up to the Cloud Comms Summit event which is happening September 11th - 12th near Washington, DC! In this episode, our host Dominic Black (Head of Research at Cavell Group) talks to guest Anand Buch, the CEO and Co-Founder of Netsapiens, about the softswitch market and potential areas of differentiation for Service Providers in this highly competitive industry. Anand Buch studied Engineering at the College of Dupage where he received 4 associate's degrees followed by an Electrical Engineering degree at the University of Illinois, Urbana Champaign. Anand was honored to be invited by David Wang in the founding of Netsapiens in 2002 which led to him becoming Chief Executive Officer around 2006. Today, as CEO of Netsapiens inc., he leverages his multi-disciplinary experience in business and technology to guide the conception, realization, and delivery of new solutions to the marketplace. Listen to find out more, and if you can't get enough make sure you buy a ticket while there are still some available for the Summit itself where you can see Dominic, Anand and a whole host of other amazing speakers! www.cloudcommssummit.com/washington

Exodus 32:1-35

Exodus 32:1-35

In this weeks podcast we talked with David Wang about how palliative care can join forces with the emergency department to improve care for the serious ill. This conversation was motivated in part by a recent expert consensus statement on key knowledge and skills standards about hospice and palliative medicine for emergency medicine providers. What should the core training be? How do emergency providers feel about palliative care? How can palliative care services that are typically available bankers hours work with the emergency department, open 24-7?

David Wang is an expert in the field of technology. He knew he wanted to get into real estate but didn't have any desire in becoming a realtor. His desire to get into the real estate market and ability to identify consumer needs has led him into a project to platform for homeowners wanting to sell their homes themselves. __ #VSMRealEstate is a full-service real estate firm with a broad range of expertise and capabilities that extend from the acquisition of investment to the financing & management of assets, brokerage, leasing, and property management. There’s a reason why our clients come back to us time and again, and why we’ve been around as long as we have. Integrity and professional competence are at our core, and we are here and ready to get to work – for you. We are dynamic and we strive to deliver an extraordinary level of service driven by results. __ We are born in the Twin Cities, a community which is more than a collection of buildings and green space. It is a collection of homes, businesses, and the hub of new and creative ideas that help to transform the world.​ Whether through our exclusive listings, our partnerships or our extensive industry network, our team is dedicated to understand our clients and help them finding their perfect space in the Twin Cities.​ VSM endeavors to invest, own and manage residential and mixed use communities that enhance the lives of residents while strengthening neighborhoods physically, socially and economically. __ Subscribe to exclusive content here: www.vsmrealestate.com/resources Follow Us Online: Instagram | instagram.com/vsm_real_estate Facebook: | facebook.com/vsmrealestate Website: | vsmrealestate.com Soundcloud | @vsmrealestate Twitter | twitter.com/vsmrealestate iTunes Podcast | itunes.apple.com/us/podcast/vsm-r…d1156931697?mt=2 Stitcher Podcast | www.stitcher.com/podcast/the-diff…al-estate-advice

One of the pillars of the HPE Storage Point of View is "Predictive". In this episode I'm joined by Rod Bagg, VP of Analytics and Customer Support and David Wang, Director of Product Marketing to dive into why it's an important area of focus and how customers benefit.

NEW: Download the Limitless Laowai Consulting App for free by searching in your app store or clicking http://subsplash.com/limitlesslaowai/app!! All Limitless audio, video, wellness and event content designed to unlock greater freedom and possibility in your life! Over the 10 years I've lived in Shanghai, I've heard conflicting things about the safety of the water we use on a daily basis. I had the privilege of sitting with David Wang, co-founder of GreenWave to settle the dispute once and for all. Is the water safe? What options do we have? And how can we make informed choices for our families? This podcast is in conjunction with Community Center Shanghai's 'Shanghai 123' Free Orientation for New Arrivals program. For more information on the orientation, check out http://communitycenter.cn/shanghai123. We welcome your feedback! Email Ally at ally@limitlesslaowai.com. A special thanks to this episode's sponsor, Concordia International School Shanghai. Discover more online at www.concordiashanghai.org.

After a series of recent high profile information security breach incidents, the role of Chief Information Officers, particularly their role in information security risk management, has been in a heated debate among practitioners. However, little is known in academic literature about how a CIOs' risk aversion level affects the effectiveness of information security management. Using reported information security breach incidents during 2003-2015, this study examines how a CIO's risk aversion level is associated to the possibility of information security incidents. In addition, we investigate the moderating effect of CEOs' risk aversion level and whether the CIO is on the board on the aforementioned effect. Our preliminary results show that a CIO's risk aversion level is significantly associated with a lower likelihood of information security breaches. We further document that such association varies depending on types of security breaches. About the speaker: Tawei (David) Wang is currently an Assistant Professor at DePaul University. He received his Ph.D. from Krannert Graduate School of Management, Purdue University. Before joining DePaul University, he was a faculty member at the University of Hawaii at Manoa and National Taiwan University. His research interests are IT management and information security management. His papers have appeared in several leading journals, including Information Systems Research, Decision Support Systems, European Journal of Information Systems, Information and Management, Information Systems Journal, Journal of Accounting and Public Policy, Journal of Banking and Finance, Journal of Information Systems, Journal of Organizational Computing and Electronic Commerce, among others.

After a series of recent high profile information security breach incidents, the role of Chief Information Officers, particularly their role in information security risk management, has been in a heated debate among practitioners. However, little is known in academic literature about how a CIOs’ risk aversion level affects the effectiveness of information security management. Using reported information security breach incidents during 2003-2015, this study examines how a CIO’s risk aversion level is associated to the possibility of information security incidents. In addition, we investigate the moderating effect of CEOs’ risk aversion level and whether the CIO is on the board on the aforementioned effect. Our preliminary results show that a CIO’s risk aversion level is significantly associated with a lower likelihood of information security breaches. We further document that such association varies depending on types of security breaches.

David Wang is a genius-level engineer and computer scientist. He got a PhD at MIT focusing on planning for autonomous systems. He also holds degrees in techniques for improving software reliability, Aeronautics & Astronautics, Electrical Engineering, & Computer Science from MIT. His work experience includes time at JPL, Draper Labs, Northrop Grumman, Pratt & Whitney, Boeing, and DARPA. At MIT, he helped teach a variety of courses including one in Principles of Autonomy and Decision Making. . Since graduating, he’s helped found a school in Boston that has no courses, no subjects, no classes, and no grades. In other words, he’s in the process of redefining education as we know it. David is an intellectual powerhouse and also, a genuinely good guy. Reach out to David at www.nuvustudio.com Enjoy episode 7 of Hacker Practice with David Wang: [2.45] David explains how we have come out of “Artificial Intelligence Winter” and why AI is about to take off [5.10] AI ethics and morality and the end game [5.45] David discusses how codifying algorithms lead him to forging a career in AI [7.15] David discusses why following your hobby is a very important step in figuring out what you are on this planet to do: David enjoyed building computers from scratch Built a processor from logic gates in his spare time after studying [13.30] David describes what it’s like working on research projects with DARPA – Advanced research project agency of the defence department. ARPA is most famous for creating the internet. [14.45] Learning interesting topics – PHD automated planning and scheduling – AI subcategory [16.45] David describes AI planning and scheduling in detail! Ask how would we describe the world to a computer with true or false statements E.g. is the coffee cup on the table? True/false We then have a language which we can use to describe the world as is and how we want it to be (known in the AI world as “the goal”) Describe an action with a set of preconditioned statements that create a set of effects. Planning and scheduling involves sequencing these actions to get from your starting point to the goal. [21.10] David describes planning system projects he worked on at MIT involving decision making algorithms to block malicious hacking tactics. [23.20] David discusses the two types of hackers that are most dangerous [25.00] David describes his experiences of working on AI robotics projects for Boeing Why programming frameworks haven’t innovated until now [34.20] How video gaming was David’s gateway drug to programming. David also describes how we can take learnings from video game construction to the real world and contextual AI applications. [38.20] David discusses the concept, “you can do anything, but you can’t do everything” [40.40] David describes personal hacks he has for learning Start by asking why something is the way it is and understand the reasons behind something. Is there an intuition that is extractable that will allow you to remember why something is the way it is. [42.45] David talks about working on Augmented Reality applications in smart homes [44.30] Hacks to remember the names of people you meet [49.00] David gives an example of how AR in the smart home context, could be used to help a non-technical person, solve a technical problem, without the need for a technician [50.40] David gives his insights on Virtual Reality (VR) applications [54.00] Discussion on learning and facing adversity [56.40] David discusses his experiences working on the F-35 jet fighter David would essentially imagine all the different ways the plane could fail and reverse engineer solutions to prevent failure How David used the spiral development cycle to understand how the F-35 worked [1.04.00] Complexity comes not necessarily from the technology but from the number of moving parts David talks space exploration applications [1.08.10] How David deals with the isolation of being at the top of a field [1.10.20] Why it is so important to understand students underlying motivators to learn [1.13.20] Why it is important to decide if college is the right medium for students. College shouldn’t be used as the only time to decide what you want to do with your life. [1.16.45] David discusses why he started NuVu and shares his insights on teaching intuition By realising that the projects that really piqued his interest during studies were all based on extracurricular activities, David went out to challenge the existing education model. [1.20.30] What it’s like to run a school which has no classes, subjects or grades Students need to come up with an idea they are super passionate about. They are then taught how to turn it into a great idea. Students skills are then develop to turn this idea into a solution. The difference from formal learning here, is that they are invested in learning these skills because they are passionate, as opposed to being forced. Encourage students to understand the fundamental concepts of human centred design thinking when ideating and developing their solution [1.25.20] Justus gets David to deconstruct an idea using his teaching methodology. Spoiler: There is a lot of asking “why” Focus on solving a problem by stripping down an idea to its absolute rawest form. Minimum viable product (MVP) [1.31.30] How to not avoid losing sight of your original idea in the face of pivoting [1.34.00] What someone could expect as a new student at NuVu [1.37.10] How to start a school like NuVu on the cheap NuVu is a private educational business that is not accredited. How important is accreditation? In the case of NuVu, it isn’t. Ask, what does success look like for students leaving your school? NuVu wants to create the innovators of the future. There is a strong emphasis on soft skills. [1.43.30] The goal of working in a team is to create a giant brain [1.46.30] David discusses a seasonal effective disorder (SED) project some of his students are working on [1.48.20] What a parent who wants to send their child to NuVu need to know [1.49.30] How David plans on scaling by helping existing schools adopt the NuVu education model Use Maker Spaces more effectively [1.53.20], David asks us to think about what success means to you and is college critical on that path to success? You can find David at www.nuvustudio.com

Susan Daruvala (Senior Lecturer in Chinese Literature, Cambridge University) Zhang Ailing and Stella Benson: Imagery and Understanding David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in this concluding symposium. Confirmed Speakers: Professor Qian Jun (University of Newcastle) Professor Michel Hockx (SOAS) Professor Hans van de Ven (University of Cambridge) Dr Julia Lovell (Birkbeck College, University of London) Dr Susan Daruvala (University of Cambridge)

Hans van de Ven (Professor of Modern Chinese History, Cambridge University) The Chinese Maritime Customs’ Invention of a Chinese National Language David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in this concluding symposium. Confirmed Speakers: Professor Qian Jun (University of Newcastle) Professor Michel Hockx (SOAS) Professor Hans van de Ven (University of Cambridge) Dr Julia Lovell (Birkbeck College, University of London) Dr Susan Daruvala (University of Cambridge)

David Derwei Wang (Edward C. Henderson Professor of Chinese Literature, Harvard University David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in this concluding symposium. Confirmed Speakers: Professor Qian Jun (University of Newcastle) Professor Michel Hockx (SOAS) Professor Hans van de Ven (University of Cambridge) Dr Julia Lovell (Birkbeck College, University of London) Dr Susan Daruvala (University of Cambridge)

Qian Jun (Chair of Chinese Studies, Newcastle University): Literariness (Wen) and Character (Zhi) of Modern Chinese Prose David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in this concluding symposium. Confirmed Speakers: Professor Qian Jun (University of Newcastle) Professor Michel Hockx (SOAS) Professor Hans van de Ven (University of Cambridge) Dr Julia Lovell (Birkbeck College, University of London) Dr Susan Daruvala (University of Cambridge)

Michel Hockx (Professor of Chinese, SOAS, and Director of SOAS China Institute) Linguistic, Formal, and Moral Experiments in Contemporary Chinese-Language Poetry on the Internet David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in this concluding symposium. Confirmed Speakers: Professor Qian Jun (University of Newcastle) Professor Michel Hockx (SOAS) Professor Hans van de Ven (University of Cambridge) Dr Julia Lovell (Birkbeck College, University of London) Dr Susan Daruvala (University of Cambridge)

Julia Lovell (Senior Lecturer in Modern Chinese History, Birkbeck College) Violent Times, Violent Language: Contemporary Chinese Fiction and the Mimetic Fallacy David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in this concluding symposium. Confirmed Speakers: Professor Qian Jun (University of Newcastle) Professor Michel Hockx (SOAS) Professor Hans van de Ven (University of Cambridge) Dr Julia Lovell (Birkbeck College, University of London) Dr Susan Daruvala (University of Cambridge)

David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in a concluding symposium on Wednesday 21 May 2014. Abstract Sinophone Studies—the study of Sinitic-language cultures born of postcolonial and postsocialist influences—has represented a forceful intervention with Chinese Studies since the turn of the millennium. This talk seeks to examine the recent developments of Sinphone Studies and reflect on their theoretical premises and geopolitical implications. The talk is divided into three parts. The first part takes issue with the definition of “Sinophone” as a homogeneous discourse and highlights the potential of heteroglossia in any Sinophone articulation. The second part proposes "post-loyalism” as a dialogical critique of the extant paradigm which is rooted primarily in post-colonialism and a renewed Cold-War spatial imaginary. The third part introduces the poetics of “disposition,” as inspired by the traditional Chinese poetics of shi, and suggests that beyond the geopolitics of “root,” scholars should look into the momentum arising from the aesthetic and humanistic engagement with Sinophone Studies.

David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in a concluding symposium on Wednesday 21 May 2014. Abstract This talk proposes that we rethink the critical paradigm of modern Chinese literature in terms of “literary thought” or wenlun. As opposed to “literary theory” or lilun, which derives its conceptual and rhetorical thrust primarily from Western discourse, Chinese literary thought refers to a group of diverse texts, which in turn belong to distinct genres, occasions, and purposes. It tries to “explain the role literature plays in a civilization and to describe literature and literary works in terms that have resonance in other areas of intellectual and social life.” The talk introduces the lyrical in epic time as an exemplary case of modern Chinese literary thought. It critiques the conventional wisdom that associates lyrical representation with romantic escapade and sentimental solipsism, calling attention instead to modern writers’ and critics’ reappraisal as well as invention of the “lyrical tradition” of China. In particular, it features the engagements undertaken by intellectuals such as Shen Congwen (1902-1988), Chen Shixiang (1912 -1971) and Jaroslav Průšek (1906-1980) in the mid-twentieth century, a time often regarded as the “epic.” As such, the lyrical in epic time constitutes a significant part of modern lyrical discourse which includes articulations from Heidegger to Benjamin, Adorno, Brooks and de Man.

David Der-wei Wang (Edward Henderson Professor in Chinese Literature at Harvard University, Director of CCK Foundation Inter-University Center for Sinological Studies, and Academician, Academia Senica) will give a series of three public lectures on The Chinesesness of Chinese Literature and participate in a concluding symposium on Wednesday 21 May 2014. Abtract This talk examines modern Chinese literature not as a corpus of texts but as a constellation of tastes, discourses, occasions, and productions contested by historical dynamics. The talk starts with the year 1908, when Lu Xun introduced “Mara Poet” as a modern agent to “pluck” one’s heart and thereby transform China. This Mara Poet underwent multiple incarnations in the subsequent decades, from a romantic iconoclast to a modernist rebel and a revolutionary fighter, finally becoming a Maoist Cadre. Meanwhile, since the 1920s, modern Chinese literary culture has been occupied by another figure, Alfred Nobel, as the country was striving to catch up with world literature. When Gao Xingjian and Mo Yan were awarded the Nobel Prizes in the new millennium, however, that produced more questions than answers as to the meaning and function of Chinese literature. From Mara to Nobel by way of Mao, modern Chinese literary culture has been conceived, produced, circulated, and consumed in a multitude of ways. The talk will focus on the following topics: the changing fields of production, the fashioning of literary subjectivity, and the negotiation of literary values, during the pre-May Fourth era, the eve of 1949, and the postsocialist era.

Sunday message from Westgate Chapel, Edmonds, Washington.

Sunday message from Westgate Chapel, Edmonds, Washington.

How do we get boys to grow up into virtuous men? This week on SL Radio we speak to Jason Craig, Director of Program and Training at Fraternus, a media ministry for mentoring boys; Mark Matthews tells us what's good about Hollywood and David Wang of Critical Mass returns for a chat. ...

How do we get boys to grow up into virtuous men? This week on SL Radio we speak to Jason Craig, Director of Program and Training at Fraternus, a media ministry for mentoring boys; Mark Matthews tells us what’s good about Hollywood and David Wang of Critical Mass returns for a chat. ...

Sunday message from Westgate Chapel, Edmonds, Washington.

Sunday message from Westgate Chapel, Edmonds, Washington.

We conclude this year's Summer Edition of S+L Radio, with a special program recorded live from the Unity Awards and Conference, which took place in Calgary. Join me as I speak to many of our Canadian nominees (and former S+L Radio guests), David Wang, Chris Bray, David MacDonald and Lor...

We conclude this year’s Summer Edition of S+L Radio, with a special program recorded live from the Unity Awards and Conference, which took place in Calgary. Join me as I speak to many of our Canadian nominees (and former S+L Radio guests), David Wang, Chris Bray, David MacDonald and Lor...

This paper investigates the relationship between information security related disclosures in financial reports and the impacts of information security incidents through cross-sectional and cluster analysis. First, by drawing upon the theories of disclosures in the accounting literature, we examine the effect of the number of disclosures on stock price reactions to information security incidents from 1997 to 2006. Our findings suggest that first-time disclosed information security risk factors in financial reports can mitigate the impact of information security incidents on business value. Second, a cluster analysis is performed on the disclosures in financial reports before and after the incidents. The results demonstrate that companies react to information security incidents by disclosing additional and more specific risk factors in subsequent financial reports. A prediction model is also built to classify disclosures as a belonging to a firm reported in the as breached or non-breached. The model can correctly classify a disclosure with approximately 75% accuracy which help investors and auditors assess information provided by the firm. This paper not only contributes to the literature in information security and accounting but also sheds light on how managers can evaluate their information security policies and convey information security practices more effectively to the investors. About the speaker: Ta-Wei "David" Wang is currently a Ph.D. student in Management Information Systems at Krannert Graduate School of Management, Purdue University. He received his B.B.A and M.B.A from National Taiwan University in Taiwan. He is also a Certified Public Accountant in Taiwan and Certified Internal Auditor. His research interests are information security and knowledge management.

This paper investigates the relationship between information security related disclosures in financial reports and the impacts of information security incidents through cross-sectional and cluster analysis. First, by drawing upon the theories of disclosures in the accounting literature, we examine the effect of the number of disclosures on stock price reactions to information security incidents from 1997 to 2006. Our findings suggest that first-time disclosed information security risk factors in financial reports can mitigate the impact of information security incidents on business value. Second, a cluster analysis is performed on the disclosures in financial reports before and after the incidents. The results demonstrate that companies react to information security incidents by disclosing additional and more specific risk factors in subsequent financial reports. A prediction model is also built to classify disclosures as a belonging to a firm reported in the as breached or non-breached. The model can correctly classify a disclosure with approximately 75% accuracy which help investors and auditors assess information provided by the firm. This paper not only contributes to the literature in information security and accounting but also sheds light on how managers can evaluate their information security policies and convey information security practices more effectively to the investors.

Critical Mass is an awesome Catholic modern rock band from Canada, and frontman David Wang joins us for this podcast. Also features a first-person account of John Paul II's funeral from a youth minister who was there.

Critical Mass is an awesome Catholic modern rock band from Canada, and frontman David Wang joins us for this podcast. Also features a first-person account of John Paul II's funeral from a youth minister who was there.